Poster

Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease

American Society for Preventative Cardiology

2026

Poster

Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM Study

Heart in Diabetes

2026

Poster

Characterization of Individuals With Resistant Hypertension and Post-Dexamethasone Suppression Test Cortisol <1.2, 1.2–1.8, and >1.8 μg/dL: Results From the MOMENTUM Study

Annual Meeting of The Endocrine Society

2026

Poster

High Prevalence of Endogenous Hypercortisolism in Patients With Type 2 Diabetes and Resistant Hypertension: Results From the MOMENTUM Study

American Diabetes Association

2026

Presentation

Effects of Mifepristone in People With Difficult-to-Control T2D and Hypercortisolism on GLP-1 RAs

American Diabetes Association

2026

Poster

Relacorilant Treatment Improves Glycemic Control Among Individuals With Cushing Syndrome (Endogenous Hypercortisolism) and Hyperglycemia on Glucagon-Like Peptide-1 Receptor Agonists: Insights From a Phase 3 Study

American Association of Clinical Endocrinology

2026

Poster

Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Difficult-to-Control Type 2 Diabetes: Results From Two Large, Prospective Studies

Annual Meeting of The Endocrine Society

2026

Presentation

Prevalence and Clinical Impact of Hypercortisolism in Patients With Resistant Hypertension: Primary Results From the MOMENTUM Study

American College of Cardiology

2026

Presentation

Co-secretion of Cortisol and Aldosterone in Individuals With Resistant Hypertension: Results From the MOMENTUM Trial

American Association of Clinical Endocrinology

2026